United Kingdom
March 27, 2015
Plant Health Care plc, ("PHC"), a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce several changes to its Board.
Dr. Christopher Richards, formerly Non-Executive Chairman of PHC, will become Executive Chairman with effect from 1 April 2015. Dr. Richards will lend support to the management team in developing strategy and in investor relations as the Company pursues new growth opportunities.
The Company is also pleased to welcome William ("Bill") M. Lewis, who will join the Company as a Non-Executive Director with effect from 1 April 2015. Mr. Lewis, 54, is currently President and CEO of Summit Agro USA, LLC, an agro chemical joint venture between Sumitomo Corporation and ISK Biosciences. Between 2006 and 2013, Mr. Lewis held senior roles within Arysta LifeScience, having previously worked at Syngenta Crop Protection (2000 - 2005) and held international roles at Zeneca/ICI (1984 - 2000). Mr. Lewis is also currently a Director of Four L's Enterprises Inc. and Four L's Real Estate Holding Company LLC.
Also, as previously announced, Dr. Richard H. Webb, formerly a Non-Executive Director, became an Executive Director of Plant Health Care plc as of 1 January 2015. Dr. Webb is now responsible for supporting our Chief Scientific Officer, Dr. Zhongmin Wei, as the company continues to expand its research and development programme. Dr. Webb will step down from the Audit Committee after the firm's annual general meeting and is being replaced by James Ede-Golightly, who joined the Audit Committee on 16 January 2015.
Dr. Christopher Richards, Chairman commented: "On behalf of the entire Board, I would like to extend a warm welcome to Bill Lewis as Plant Health Care's new Non-Executive Director. Bill is an experienced executive who, throughout his career, has an outstanding track record in building successful businesses, both in North America and globally. A proven leader, Bill will bring with him a wealth of commercial experience from which the Company will benefit.
"With the new composition and responsibilities of the Board established, I am looking forward to working with Paul Schmidt and the rest of the management team both to ramp up sales of our current portfolio of products and to secure licences for our InnatusTM 3G peptide platform. Plant Health Care is positioned with the right people and technology to become the global leader in agricultural biostimulants."
Topics
Species
